Objective: The objective of this study was to quantify the direct medical and nonmedical costs of stroke among patients with nonvalvular atrial fibrillation in India. Methods: An observational, multicenter cost-of-illness study was conducted within large tertiary care hospitals across three metropolitan cities in India. Medical chart records of eligible patients who were hospitalized during the study period were reviewed. A standardized data collection form was designed and used to capture resources expended in the treatment and management of stroke during the inpatient stay. In addition, direct medical and nonmedical outpatient care resources and informal care burden were captured using a detailed questionnaire, following the patients' discharge. Factors associated with acute care costs were investigated using multivariate linear regression analysis. Results: Data were collected on a total of 400 patients with incident strokes. Their mean age was 61.4 Ϯ 9.4 years. About 84% of the patients were diagnosed with ischemic stroke. On average, patients spent 16 Ϯ 10 days in the hospital. Total mean direct health care costs per patient amounted to`504,973 (US $8,020) during the first year, with about 47% (mean`235,471; US $3,750) of the total costs due to the index hospitalization. The modified Rankin scale score was strongly associated with costs, whereby severely disabled patients had 32% higher costs (P ¼ 0.001) compared with moderately disabled patients during the first 3 months postdischarge. Conclusions: Overall, the financial burden associated with medical care for patients with stroke with atrial fibrillation along with rehabilitation and long-term care costs places a significant demand on health services in India.
Introduction
Stroke occurs when interruption of blood supply or leakage of blood from a blood vessel causes damage to the brain [1] . Every year, 20 million people worldwide experience a stroke, making it one of the fastest growing causes of morbidity and mortality [1] [2] [3] [4] [5] . Stroke is a predisposing factor for epilepsy, falls, and depression [3] and is a leading cause of functional impairments, with 20% of the survivors requiring institutional care after 3 months and about 15% to 30% permanently disabled [6] . Stroke is no longer considered a condition that affects the developed world. Globally, 12.6 million people suffer moderate to severe disability after stroke and of this, 8.9 million people are from low-and middle-income countries [3] . Low-and middle-income countries in the Asia-Pacific region account for 85.5% of total stroke deaths worldwide, and the number of disability-adjusted life-years in these countries is reported to be seven times that observed in high-income countries [7] . It is estimated that in India alone about 6.36 million disability-adjusted life-years are lost because of stroke [8] .
China and India have the largest populations in the AsiaPacific region and account for the highest numbers of deaths from stroke (18, 16 ,000 and 7,27,900, respectively) [9, 10] . The prevalence of stroke in India is reported to be 99 to 222 per 100,000 [10] , with about 1.44 to 1.64 million cases of new stroke diagnosed every year [3, 11] . Furthermore, studies have reported that the average age of patients with stroke in developing countries is 15 years less than that in developed countries [12] . Results from studies conducted in India have shown that about 10% to 15% of strokes occur in people younger than 40 years, with about 21% to 48% of strokes being caused by atherosclerotic large artery occlusive diseases [11, 13] . Although stroke mortality rates are declining or stabilizing in developed countries, experts are concerned about the emerging epidemic of stroke in India [14] . As life expectancy is projected to increase, India will likely face a significant socioeconomic burden to meet the cost of managing stroke [15] . A recent study identified that 7% of medical and 45% of neurological admissions were due to stroke, with a fatality rate of 9% at hospital discharge [16] .
Atrial fibrillation (AF) is an important risk factor for stroke [17] [18] [19] [20] . Compared with the general population, people with AF have a fivefold increased risk of stroke [17, 18] . AF is responsible for about 20% of ischemic strokes [17] [18] [19] [20] . The risk of stroke in patients with AF increases with age and with the addition of other risk factors (e.g., high blood pressure, age 4 75 years, congestive heart failure, previous stroke or transient ischemic attack or thromboembolism, and diabetes) [21] [22] [23] . AF-related strokes are predominantly cardioembolic, more severe, and cause greater disability and have worse outcomes (20% likelihood of death and 60% disability) than does stroke in people without AF [17] [18] [19] [20] 24, 25] . Given that AFrelated strokes tend to be more severe, they result in higher direct medical patient cost annually compared with non-AF-related stroke. The total societal burden of AF-related stroke reaches €13.5 billion per year in the European Union alone [26, 27] . Furthermore, this financial burden is higher for patients and their families in countries such as India where there is a greater level of out-ofpocket expenditure on health care.
Cost-of-illness studies highlight the economic magnitude of an illness/condition on society or a part of society. These studies have been frequently used by policymakers such as the National Institutes of Health and the Centers for Disease Control and Prevention in the United States and have been used in part to describe resource allocations for various diseases [28] . Because limited data are available regarding resource utilization and costs associated with the management of stroke in India, the objective of the current study was to estimate the average direct medical and nonmedical costs of stroke among patients with nonvalvular AF.
Methods

Study Overview
An observational, multicenter cost-of-illness study was conducted at hospitals offering specialty services in neurology across three metropolitan cities, namely, Gurgaon, Mumbai, and Bangalore in India. Based on the Sancd report (2008), these cities had reported a high prevalence of stroke cases. A site feasibility analysis was conducted in each city, and chief medical officers from hospitals that met the study criteria were contacted to understand their interest in participating in the study. Hospitals were selected on the basis of factors such as bed size, presence of neurology/stroke unit ward, availability and access to patient medical charts and discharge records, ethics committee approval process, and willingness of the key opinion leader and hospital to participate in the study. Hospitals that consented to participate in the study were the Holy Family, Saifee, and Lilavati hospitals in Mumbai; St. John's Medical College in Bangalore; and the Medanta Institute of Neurosciences in Gurgaon. The study was conducted from a societal perspective and was approved by the hospital ethics committee board at each participating center. All participating patients completed an informed consent form at the start of the study.
Patient inclusion criteria for the study were as follows: diagnosis of ischemic or hemorrhagic stroke (primary and recurrent) for patients older than 18 years, a prior diagnosis of AF, AF with at least one additional risk factor (i.e., previous ischemic stroke, transient ischemic attack, or systemic embolism, left ventricular dysfunction, age Z65 years, with either diabetes mellitus, history of coronary artery disease, or hypertension). Patients were excluded from the study on the basis of evidence of any of the following conditions: 1) cancers, fatal renal, hepatic, or respiratory insufficiency; 2) disabling and progressive neurological diseases (multiple sclerosis, Parkinson's disease); 3) dementia; and 4) refusal or withdrawal of patient informed consent to participate in the study.
Medical chart records of patients who met the above inclusion criteria and were hospitalized from January 1, 2010, through December 31, 2011, were reviewed. A standardized data collection form was designed to capture demographic and clinical characteristics of patients and resources expended for the treatment and management of stroke during their inpatient stay from patient medical charts. The data collection form captured information on the following parameters: patient demographic characteristics, medical history/comorbid conditions, pharmacological management, surgery, diagnostic/laboratory tests, and hospital length of stay (LOS). Because India is predominantly an out-of-pocket payer market, there are limited data, if any, available on hospital charges; therefore, hospital costs were derived from per patient billing records at each site. All prices are 2012 values. A trained on-site reviewer performed data collection at each participating center. All case report forms were verified for completeness and accuracy of data. Data collected for the study were de-identified and kept confidential at an onsite password-protected secure server.
Structured interviews using the modified Rankin Scale (mRS) [29] were conducted to assess the functional disability due to stroke among all participating patients within 1 week of hospital discharge. The mRS is a global disability scale used to measure the degree of disability or dependence in daily activities of people who have suffered a stroke or have other neurological disabilities. It is a commonly used clinical outcome measure for stroke in clinical trials with a scale from 0 to 6, where 0 indicates "no symptoms" (perfect health) and 6 indicates "death."
Because no data were available regarding outpatient resource use and cost associated with stroke postdischarge, two questionnaires-one to be completed by participating patients and the other to be completed by physicians-were developed. Patients who met the inclusion criteria and agreed to participate in the study completed the questionnaire at 3 months postdischarge via telephonic or face-to-face interviews. The questionnaire captured information regarding the frequency of clinic visits with neurologists, cardiologists, or general practitioners, laboratory and imaging tests, rehabilitation services (physiotherapy, speech therapy, etc.), specialized nurse services, additional strokerelated hospitalizations, and stroke-related medications (name, dose, and frequency were obtained by asking the patients to refer to their prescription records). Patients were also requested to provide estimates for travel costs incurred to obtain medical services and modifications made to their home poststroke during this period. Patients receiving informal care from caregivers were requested to estimate the cost of informal care on the basis of the number of days of lost productivity (unpaid leave) by the caregiver. Outpatient cost for each patient was estimated by multiplying the average cost for each resource unit by its frequency for the acute 3-month period postdischarge.
The physician questionnaire captured data for outpatient services such as the frequency of outpatient clinic visits, laboratory and imaging tests, and stroke-related medications over the remaining 9 months after the "acute phase." This questionnaire was completed by five neurologists from the three cities where the study was conducted. Outpatient costs for this period were calculated by multiplying the average per visit/service costs by the total number of visits/services used over the 9-month period. While estimating the annual costs in the study we assumed that no patient had a recurrent stroke event during the study period. Table 1 shows a list of health resource items investigated and outlines the resources that were estimated in the study.
Statistical Analyses
Statistical analyses were conducted with SPSS version 19.0. Descriptive analyses were used to describe the continuous and
categorical data of patients. To evaluate costs of stroke management during index hospitalization and the follow-up period in relation to sociodemographic and clinical characteristics, we performed a series of bivariate analyses using nonparametric tests (Mann-Whitney and Kruskal-Wallis). Multivariate linear regression analyses were performed to determine factors significantly associated with costs incurred by patients with stroke during the acute phase. Variables investigated were age, sex, major clinical events in the patient's history, stroke risk factors, and disability level (mRS score). Because of non-normal distribution of cost data, all costs were logarithmically transformed to run the three regression models. This transformation allowed us to use parametric methods and resulted in a model with better goodness of fit. All P values of o0.05 were considered significant.
Results
Of the 1565 stroke cases registered across all participating hospitals during the study period, we collected data on a total of 400 patients who met the inclusion criteria over the course of the study. The sociodemographic and clinical characteristics of patients are represented in Table 2 . The mean age of participating patients was 61.4 Ϯ 9.4 years, with a predominance of men (62%). About 43% of the patients consumed tobacco and around 25% consumed alcohol. Majority of the study population (82.5%) comprised either homemakers or those who had retired from the workforce. About 84% of the patients were diagnosed with an ischemic stroke. Hypertension (53%) and diabetes (40%) were the most commonly documented risk factors among these patients. Nearly 7% of the patients had both hypertension and diabetes. Furthermore, nearly 42.5% of the patients reported severe disability on the mRS. Death was documented at time of discharge for 32 patients (8%) who were significantly older (79 vs. 61.4 years; P o 0.001) and were more likely to be women (68.7% vs. 32%; P o 0.001).
On an average, patients were in the hospital for 16 Ϯ 10 days for the stroke event and the LOS was not significantly different across different settings of care. After discharge, most (83%) patients used follow-up general practitioner services, followed by specialist visits (65%) and diagnostic procedures (69%). Total mean health care costs per patient were`504,973 (US $8,020) (median`455,566; US $7,235) during the first year (Table 3) . About 47% (mean`235,471; US $3,739) of the total costs were due to index hospitalization, while outpatient follow-up care accounted for about 40% of health care costs. Other health care costs related to nursing care, home modifications, and informal care amounted to an average of`69,107 (US $1,098). Although the magnitude of costs during hospitalization was similar for hemorrhagic and ischemic strokes, patients with hemorrhagic stroke had follow-up health care costs at 3 months postdischarge that were higher (`92,631 vs.`81,677; P ¼ 0.08) than those of patients with ischemic stroke. This result, however, was not statistically significant. Cost predictions were further investigated using multiple regression analysis. Only demographic and clinical characteristics were used to predict differences in costs. Results of multiple regression outlined factors that were significantly and positively associated with costs such as being a male patient, having diabetes, having had a hemorrhagic stroke, and having a higher mRS score (Table 4) . Patients with severe disabilities had 32% higher costs than did patients with moderate disabilities during the first 3 months postdischarge.
Discussion
Patients with AF tend to experience more severe strokes, giving rise to significantly increased costs for acute hospitalization due to more intense and prolonged level of care. The results of the present multicenter study conducted in India estimate the total costs of stroke among patients with AF to be`504,273 (US $8,020) in the first year after the event, which are high compared with the national average annual per capita income of`61,560 (US $978). The largest contributor of total direct medical cost in the study was initial hospital LOS during the acute phase of the event followed by outpatient care during the first 3 months postdischarge. 2 0 1 4 ) 2 0 In addition to cost comparisons, we compared the health care resources used across similar studies. The mean LOS for index hospitalization in our study was about the same as the mean number of inpatient days (15 Ϯ 10 days) reported in a study by Yoon et al. [30] in South Korea as well as in the Berlin Acute Stroke Study [31] . The LOS reported in our study, however, was less than the mean LOS (18-20 days) reported in a study by Wei et al. [32] in China, which can be attributed to differences in treatment patterns between countries. The mean index hospitalization costs reported in this study were similar to the cost reported in a study by Yoon et al. in South Korea (US $3,750 vs. US $3,595) [30] . Because there are very few studies that report the burden of stroke with respect to resource use and costs in the Asia Pacific region, we compared the results of our study with data from two European cost-of-illness studies among patients with AF and stroke using similar methodology. These studies adopted a societal perspective, with an incidence-based approach and 1-year follow-up and produced estimates of €19,953 (`485,140; societal costs) and €20,239 (`552,907; societal costs) per patient per year in Italy and Germany, respectively [32, 33] . In addition, this study reported rehabilitation services to account for about 39% of the total health care costs in the first year postevent, which were similar to the results reported in a registry study among patients with stroke in Germany (37%) as well as data reported from an Italian study (35%) [32] [33] [34] .
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Informal care plays a substantial role in total care provided to patients with stroke. There are limited data, however, on costs associated with informal care in developed and developing countries. In a recent literature review on cost of stroke studies that used patient-level data, authors showed that only eight (7%) of the studies included informal care costs [35] . We tried to fulfill the existing gap by providing estimates of informal care costs determined via structured interviews with patients and caregivers. Our estimates were much lower than the results of a few similar studies that showed informal care costs to be a major component of the total cost of stroke. This could be because the majority of our sample (comprising of men) reported their wives, who were homemakers, to be their primary caretakers, thereby reducing the impact of this resource category on the overall cost of stroke-related care.
With both its prevalence and the associated death rate increasing, there is an urgent need to improve the management of AF, in particular to prevent the most common fatal consequences, such as stroke. Although the current treatment for stroke with vitamin K antagonists, such as warfarin, can be effective, it has been well documented that proper dosing and close monitoring are imperative to attain an optimal level of anticoagulation to balance the risk of stroke with an increased risk of bleeding, particularly in elderly patients [36] [37] [38] . Effective screening of patients and appropriate anticoagulation therapy can help prevent many types of AF-related strokes and improve overall patient outcomes. An interesting finding of our study was that only 15% of the patients in our study sample had received or used any anticoagulation therapy with warfarin or at least received aspirin before their stroke event. This highlights the underuse of oral anticoagulation among this patient population, which could be due to the increased risk of bleeding, drug and food interactions, and inconvenience (routine blood monitoring) associated with warfarin. Newer novel oral anticoagulants, however, have demonstrated an effective and safe therapeutic profile with fewer drug/food interactions and no requirements for constant coagulation monitoring, thereby offering a potential to increase adherence to therapy and improve outcomes for patients [27, 29, 35] .
Despite careful design and implementation, our study presents some limitations. First, the study was conducted at hospitals located in large urban cities. Patients receiving treatment in these centers belonged to a higher economic class than do patients living on the outskirts of a city or in rural areas. Second, the study included both patients with ischemic stroke and patients with hemorrhagic stroke who had a prior diagnosis of nonvalvular AF. Hemorrhagic stroke could have been a result of the anticoagulants the patients were receiving but this information could not be teased out from the medical chart records. Third, the study relied on estimates regarding outpatient resource use by patients (or their caregivers) and physicians to calculate cost in the postdischarge period, which could lead to recall bias and an overestimation or underestimation of cost. Fourth, because of lack of available data, the study does not account for resource utilization and costs associated with bleeding events, which could add to the overall economic burden of stroke. Last, patients dying from stroke early would not have contributed to the cost estimate because they had to survive at least the first 3 months to contribute to the analysis (immortal time bias). 
Conclusions
Because stroke is a life-changing event that affects not only the person who may be disabled but also his or her family and caregivers, the overall financial burden associated with medical care for patients with stroke and AF places a significant demand on health services in India. Utility analyses show that a major stroke is viewed by more than half of those at risk as being worse than death [36] . Together with loss of time in employment by the patient as well as the caregiver, stroke adds an overall significant burden on society. A proportion of these costs may be preventable by lifestyle changes and primary and secondary prevention programs. This possibility is of paramount importance in terms of public health because progressive aging of the population will otherwise cause an increase in patients with stroke and consequently an increase in health care expenditure. By laying a foundation for understanding costs of health care services, data from this study can contribute toward making informed decisions on allocation of scarce resources while maintaining quality care for patients with stroke. Furthermore, future studies in India should focus their efforts on understanding the humanistic burden of stroke on patients and their caregivers because the condition can have a devastating impact not only on the individual but also his or her caregivers and family. GP, general practitioner; ICU, intensive care unit.
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